Free tool
Stocks listed on Nasdaq GM
We cover 172 companies listed on Nasdaq GM. The median market value in the group is $675.78M. Across the group, the median move over the past trading day is −0.61%. 56% of the 172 with a 200-day average trade above it. Price change over the past year runs from −57.8% to +224.9% across the middle 80 percent of the group, with a median of +21.8%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
172 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| GHRS | GH Research PLC | $1.99B | Small cap | +112.84% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| SEPN | Septerna, Inc. | $1.88B | Small cap | +218.81% |
| PSNL | Personalis, Inc. | $1.82B | Small cap | +257.32% |
| LMAT | LeMaitre Vascular, Inc. | $1.81B | Small cap | −16.20% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| ALVO | Alvotech | $1.75B | Small cap | −38.85% |
| ANIP | ANI Pharmaceuticals, Inc. | $1.71B | Small cap | −18.85% |
| MAZE | Maze Therapeutics, Inc. | $1.69B | Small cap | +113.27% |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| LBRX | LB Pharmaceuticals Inc | $1.55B | Small cap | +178.41% |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% |
| TNDM | Tandem Diabetes Care, Inc. Common Stock | $1.49B | Small cap | +74.45% |
| PAHC | Phibro Animal Health Corporation | $1.46B | Small cap | +13.01% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| MNKD | MannKind Corporation | $1.32B | Small cap | −9.51% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| STAA | STAAR Surgical Company | $1.15B | Small cap | −16.90% |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% |
| IRMD | IRADIMED CORPORATION | $1.12B | Small cap | +19.80% |
| CSTL | Castle Biosciences, Inc. | $1.04B | Small cap | +52.96% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| CLYM | Climb Bio Inc | $923.57M | Small cap | +603.72% |
| ANL | Adlai Nortye Ltd. | $884.83M | Small cap | +791.12% |
| TBPH | Theravance Biopharma, Inc. | $884.18M | Small cap | +23.41% |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% |
| AVR | Anteris Technologies Global Corp. | $865.37M | Small cap | +144.54% |
| SIBN | SI-BONE, Inc. | $861.71M | Small cap | +17.12% |
| PHAR | Pharming Group N.V. | $845.80M | Small cap | −14.47% |
| SLN | Silence Therapeutics plc | $840.94M | Small cap | +160.19% |
| ESPR | Esperion Therapeutics, Inc. Common Stock | $819.46M | Small cap | +45.87% |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% |
| NGNE | Neurogene Inc. | $768.64M | Small cap | +95.02% |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| XOMA | XOMA Royalty Corp | $710.16M | Small cap | +19.27% |
| TECX | Tectonic Therapeutic, Inc. | $703.19M | Small cap | +35.43% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| CRMD | CorMedix Inc. | $653.95M | Small cap | −40.66% |
| PRME | Prime Medicine, Inc. | $649.33M | Small cap | +4.37% |
| KIDS | OrthoPediatrics Corp. | $639.69M | Small cap | +11.10% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| EOLS | Evolus, Inc. | $579.92M | Small cap | +15.83% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +259.94% |
| BWAY | BrainsWay Ltd. | $574.70M | Small cap | +87.42% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| CERS | Cerus Corporation | $552.18M | Small cap | +109.16% |
| FLGT | Fulgent Genetics, Inc. | $545.08M | Small cap | −8.46% |
| TCMD | Tactile Systems Technology, Inc. | $532.56M | Small cap | +78.78% |
| NPCE | NeuroPace, Inc. | $503.88M | Small cap | +65.32% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% |
| LRMR | Larimar Therapeutics, Inc. | $432.15M | Small cap | +6.92% |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% |
| MASS | 908 Devices Inc. | $428.63M | Small cap | +64.60% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% |
| RCKT | Rocket Pharmaceuticals, Inc. | $401.78M | Small cap | +10.24% |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| TKNO | Alpha Teknova, Inc. | $387.63M | Small cap | +62.25% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| CLLS | Cellectis S.A. | $344.40M | Small cap | +28.09% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% |
| VNDA | Vanda Pharmaceuticals Inc. | $323.48M | Small cap | +15.80% |
| OBIO | Orchestra BioMed Holdings, Inc. | $316.15M | Small cap | +85.21% |
| RNAC | Cartesian Therapeutics, Inc. | $308.30M | Small cap | −4.09% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +129.46% |
| TLSI | TriSalus Life Sciences, Inc. | $303.56M | Small cap | −3.33% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| RXST | RxSight, Inc. | $265.36M | Small cap | −25.38% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $263.56M | Small cap | +178.15% |
| ADAG | Adagene Inc. | $258.50M | Small cap | +75.80% |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% |
| STIM | Neuronetics, Inc. | $227.07M | Small cap | −10.71% |
| CHRS | Coherus Oncology, Inc. | $224.03M | Small cap | +27.19% |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% |
| NBP | NovaBridge Biosciences | $216.26M | Small cap | −58.44% |
| MSLE | Satellos Bioscience Inc. | $198.59M | Small cap | +77.27% |
| AIRS | AirSculpt Technologies, Inc. | $196.10M | Small cap | −57.30% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| WW | WW International, Inc. | $175.98M | Small cap | −45.96% |
| QSI | Quantum-Si incorporated | $173.05M | Small cap | −31.84% |
| MENS | Jyong Biotech Ltd. | $170.30M | Small cap | −95.62% |
| FOCL | EDAP TMS S.A. | $164.75M | Small cap | +179.11% |
| NYXH | Nyxoah SA | $164.12M | Small cap | −73.74% |
| MDWD | MediWound Ltd. | $163.96M | Small cap | −25.29% |
| LFMD | LifeMD, Inc. | $156.17M | Small cap | −49.45% |
| OKUR | OnKure Therapeutics, Inc. | $155.52M | Small cap | +35.71% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| CNTB | Connect Biopharma Holdings Limited | $146.73M | Small cap | +30.90% |
| QTRX | Quanterix Corporation | $126.75M | Small cap | −41.87% |
| GUTS | Fractyl Health, Inc. | $124.77M | Small cap | −25.55% |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% |
| RANI | Rani Therapeutics Holdings, Inc. | $118.23M | Small cap | +49.45% |
| CCLD | CareCloud, Inc. | $112.18M | Small cap | −28.84% |
| BNR | Burning Rock Biotech Limited | $110.10M | Small cap | +22.54% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +32.47% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | −2.69% |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% |
| TCRX | TScan Therapeutics, Inc. | $50.80M | Micro cap | −58.43% |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% |
| YI | 111, Inc. | $32.90M | Micro cap | −46.57% |
| TELA | TELA Bio, Inc. | $31.03M | Micro cap | −60.73% |
| NEUP | Neuphoria Therapeutics Inc. | $20.86M | Micro cap | −62.23% |
| POM | Pomdoctor Limited | $7.08M | Micro cap | −76.43% |
| NOTV | Inotiv Inc | $2.79M | Micro cap | −99.37% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.